Pharma Journalist 8887 posts 0 comments

Pharmaceutical giant Merck & Co., Inc. — known internationally as MSD — has received U.S. regulatory approval for expanded use of its immunotherapy KEYTRUDA and the newer…
Read More...

Cancer-focused biotechnology company Citius Oncology, Inc. has entered an exclusive distribution agreement with international healthcare services group Uniphar to expand patient access…
Read More...

Biopharmaceutical company Madrigal Pharmaceuticals, Inc. has signed an exclusive global licensing agreement with Suzhou Ribo Life Science Co. Ltd. and its subsidiary Ribocure…
Read More...

Private equity firm Ampersand Capital Partners has announced the acquisition of contract development and manufacturing provider Purna Pharmaceuticals, signaling a strategic move to…
Read More...

A new collaboration between U.S. cell-therapy manufacturer Kincell Bio and biotechnology innovator RegCell aims to accelerate the clinical development of a next-generation…
Read More...

Clinical-stage biotechnology company Insilico Medicine and pharmaceutical commercialization group China Medical System Holdings have announced a multi-project collaboration aimed at…
Read More...

Biotechnology company Moderna, Inc. said the FDA Center for Biologics Evaluation and Research has refused to begin reviewing its biologics license application for the investigational…
Read More...

Biotechnology company Moderna, Inc. has signed a five-year strategic memorandum of understanding with the Government of Mexico, state manufacturer BIRMEX and pharmaceutical firm…
Read More...

The 5th LNP Summit, the only industry-led forum dedicated exclusively to end-to-end LNP development, is celebrating 5 years of running the flagship event. Bringing together leaders…
Read More...

Takeda has entered a multi-year collaboration with clinical-stage biotechnology company Iambic aimed at accelerating the development of new medicines using artificial…
Read More...